Paradromics Funding: $120M Raised, Series A (2023)
Paradromics is a Biotech company based in Austin. It has raised $120M in total funding. Latest round: Series A.
Paradromics funding overview
Paradromics is a Biotech company based in Austin. Paradromics has raised $120M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in January 2023. The round record for Paradromics runs through 2023; nothing later has been disclosed. Investors on record include Prime Movers Lab, Westcott Investment Group, Dolby Family Ventures, Green Sands Equity. 4 distinct backers are named across the disclosed rounds.
Paradromics at a glance
Total raised
$120M
Latest round
Series A
Latest round date
January 2023
Industry
Biotech
Headquarters
Austin
Notable investors
Prime Movers Lab, Westcott Investment Group, Dolby Family Ventures, Green Sands Equity
Frequently asked about Paradromics funding
How much has Paradromics raised?
Paradromics has raised $120M in total disclosed funding across the rounds on record.
Who has invested in Paradromics?
Prime Movers Lab, Westcott Investment Group, Dolby Family Ventures, Green Sands Equity are named among the investors backing Paradromics.
What was the latest Paradromics funding round?
The most recent disclosed round is a Series A, announced in January 2023.
Where is Paradromics based?
Paradromics is based in Austin.
What sector does Paradromics operate in?
Paradromics is tracked under Biotech from Austin, with $120M in disclosed funding.
When did Paradromics last raise?
The last disclosed Paradromics round closed in January 2023 at Series A.
We update the Paradromics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Biotech companies in Austin and their backers are listed below.
